Louisiana State Employees Retirement System’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.43M Buy
18,400
+800
+5% +$175K 0.07% 228
2026
Q1
$3.33M Buy
17,600
+800
+5% +$140K 0.06% 294
2025
Q4
$2.86M Sell
16,800
-100
-0.6% -$15.3K 0.05% 348
2025
Q3
$2.23M Sell
16,900
-400
-2% -$48K 0.04% 472
2025
Q2
$1.84M Buy
17,300
+400
+2% +$43.5K 0.03% 569
2025
Q1
$2.1M Buy
16,900
+100
+0.6% +$13K 0.04% 456
2024
Q4
$2.07M Sell
16,800
-300
-2% -$35.4K 0.04% 493
2024
Q3
$1.91M Sell
17,100
-700
-4% -$76.7K 0.04% 554
2024
Q2
$1.9M Sell
17,800
-300
-2% -$33K 0.04% 502
2024
Q1
$2.18M Buy
18,100
+400
+2% +$49K 0.04% 446
2023
Q4
$2.18M Sell
17,700
-200
-1% -$25K 0.05% 399
2023
Q3
$2.32M Sell
17,900
-800
-4% -$107K 0.05% 308
2023
Q2
$2.32M Buy
18,700
+2,000
+12% +$269K 0.05% 327
2023
Q1
$2.44M Sell
16,700
-200
-1% -$29.6K 0.06% 262
2022
Q4
$2.69M Buy
16,900
+200
+1% +$29.3K 0.07% 221
2022
Q3
$2.23M Buy
16,700
+300
+2% +$45.6K 0.07% 255
2022
Q2
$2.61M Buy
16,400
+300
+2% +$46.2K 0.07% 219
2022
Q1
$2.71M Buy
16,100
+300
+2% +$43.5K 0.06% 252
2021
Q4
$2.01M Buy
15,800
+200
+1% +$26.3K 0.04% 405
2021
Q3
$2.03M Hold
15,600
0.05% 344
2021
Q2
$2.77M Buy
15,600
+1,000
+7% +$173K 0.07% 233
2021
Q1
$2.4M Buy
14,600
+700
+5% +$115K 0.06% 269
2020
Q4
$2.29M Hold
13,900
0.07% 242
2020
Q3
$1.98M Buy
+13,900
New +$1.72M 0.09% 185

Other funds holding JAZZ

Louisiana State Employees Retirement System's JAZZ Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its Jazz Pharmaceuticals (JAZZ) stake by 4.5% in Q2 2026, buying an estimated $175K and bringing the position to 18,400 shares worth $4.43M. The position accounts for 0.07% of the portfolio, ranked #228.

Louisiana State Employees Retirement System first reported a position in JAZZ in Q3 2020 and has held it in 24 quarters since. 197 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Louisiana State Employees Retirement System held 18,400 shares of Jazz Pharmaceuticals worth $4.43M as of Q2 2026.
  • Louisiana State Employees Retirement System bought 800 Jazz Pharmaceuticals shares in Q2 2026, an estimated $175K.
  • Jazz Pharmaceuticals made up 0.07% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #228 holding.
  • Louisiana State Employees Retirement System first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • 197 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.